Tag Archives: Emmac Plc

MONDAY MORNING CBD and CANNABIS WORLD NEWS | 14th September 2020

UK HEALTH NHS will fund epileptic boy’s cannabis medicine Scotland first as cannabis-based drug approved to treat rare epilepsy on NHS EMMAC’s GDP licence: Good Distribution Practice (“GDP”) licence for the distribution of medicinal products secured with it’s Swiss pharmaceutical entity Police Chiefs Have Backed Calls for Medicinal Cannabis Cards in the UK EUROPE Medical cannabis big hit in Luxembourg. Enough

Read more

AUGUST BANK HOLIDAY NEWS REPORT | The Hemp Club

UK HEALTH Gaining Headway | GW Pharmaceuticals Carves a Niche for Cannabinoid Medicines Parents of toddler with severe epilepsy seek legal review of cannabis oil guidelines |Charlie Hughes, 3, has rare condition called West syndrome, but NHS-approved medicines have been ineffective EMMAC’s GDP licence | Good Distribution Practice (“GDP”) licence for the distribution of medicinal products secured with it’s Swiss

Read more

JULY AND AUGUST NEWS ROUND UP | THE CREAM OF THE CROP

HEALTH CBD Is A ‘Promising’ Therapy In Treating Cocaine Misuse, Meta-Study Finds CBD For Coronavirus? New Study Adds Evidence For Cannabis As Covid-19 Treatment Tests show potential for medicinal cannabis to kill cancer cells LEGISLATION Some WHO cannabis recommendations draw strong opposition at recent UN meeting EIHA blasts European agency for considering labeling CBD a narcotic UK and EU EMMAC

Read more

CBD to Psychedelics | NEWS 3rd June 2020

FSA clarifies CBD novel food application questions FastForward portfolio firm EMMAC becomes first European cannabis firm licensed to manufacture medical pharmaceutical ingredients with THC Connect with the global cannabis industry without leaving your own home Legal Cannabis hemp oil effectively treats chronic neuropathic pain: study Psychedelic drugs could help treat the mental health epidemic we’ll face after coronavirus The Czech

Read more

COVID 19 FOCUS & WORLD NEWS | 6TH APRIL 2020

GW Pharma Vet Ethan Russo Launches Endocannabinoid Startup Cannabis street prices surge under coronavirus lockdown in France COVID-19: THE TURNING POINT FOR GLOBAL CANNABIS LEGALISATION Health Canada asks cannabis industry for help with COVID-19 testing FastForward’s EMMAC Life Sciences secures permits to sell medical cannabis products in Germany The ACI launches new CBD safety certification initiative After 4-year delay, DEA

Read more

The Hemp Club | NEWS#1: 4th Jan 2020

RAMM Pharma Corp. (formerly MTC Growth Fund-I Inc.) Announces Closing of Business Combination with RAMM Pharma Holdings Corp., Medic Plast S.A. and Yurelan S.A.; Trading Anticipated to Commence…. First range of unlicensed medical cannabis products launched; EMMAC’s products already being prescribed to patients in the UK The UK Cannabis Report delivers a comprehensive and complete analysis of the UK cannabis

Read more

WEDNESDAY MARKET REPORT | Analyst’s Top 3 Cannabis Stocks Are Not What You Think + EMMAC SPECIAL

Cannabis stocks have gotten a lot of attention on Wall Street in the past year after a handful of popular Canadian growers started hitting the U.S. markets. U.S.-listed names like Canopy Growth Corp (NYSE: CGC), Tilray (NASDAQ: TLRY) and Aurora Cannabis (NYSE: ACB) get get most of the publicity. Path To Legalization In a new report, Roth Capital Partners analyst Scott Fortune says the cannabis industry has major long-term

Read more